• Home
  • Team
  • Investors
  • Facility
  • News
  • Craft

HISTORY

MOLECULE ON THE CSE

Molecule trades publicly on the Canadian Securities' Exchange as Molecule Holdings Inc. (CSE:MLCL). Click this link to obtain current market information. To access other other key financial and governance documentation, please click here.

In 2018, the founders of Molecule realized that there would be a significant barrier to entering the tightly controlled Canadian cannabis beverage market for craft innovators. Molecule was founded to fill that gap, enabling craft partners access to a market that would otherwise be closed. Since 2018, Molecule has signed 6 brand partners, and had 11 products accepted by the Ontario Cannabis Store, as well as 2 products accepted by the Société québécoise du cannabis (SQDC). Molecule was the first small-cap fully dedicated cannabis beverage company to receive its Health Canada processing license for cannabis beverages (Feb 2020), and completed its first test production run in Q4 2020. Molecule is anticipated to have product on shelves in Ontario in Q1 2021, and in Québec in Q2.

Download: Molecule $MLCL Presentation Q1 2021 v12.6.pdf

MOLECULE's VALUE PROPOSitions

Molecule is a licensed cannabis beverage company that enables craft innovators access to the tightly controlled Canadian cannabis market through brand partnerships.

Molecule's business foundation is built on high barriers to entry of market access, offering opportunity in a nascent industry.

We provide value to brand partners through creative/ technical innovation and market access. We provide value to consumers by delivering best-in-class products via our one of a kind beverage production facility and world-class team.

 

LICENSES

MARKET ACCESS

INFUSION

FORMULATION

PRODUCTION

Download the investor presentation to learn more about our journey. For a summary of our achievements, watch the video below.

* indicates required

JOIN OUR INVESTOR COMMUNITY

Independent INVESTOR DISCUSSION FORUMS*

* DISCLAIMER: Discussion forums and other independent social media groups are neither  endorsed nor monitored  by Molecule and information contained therein should not be taken as investment advice.

EMAIL CONTACT: investors(at)molecule.ca

Download: Molecule_Presentation_-_Q1_2021_v12.6-ff97a.pdf